DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Gosogliptin
Gosogliptin
Renato Wilberto Zilli Eficácia Em Longo Prazo Das
Risk of Any Hypoglycemia with New Antihyperglycemic Agents in Patients with Type 2 Diabetes: a Systematic Review and Meta-Analysis
Dipeptidyl Peptidase IV (DPP4) Inhibitors As Potential
Dipeptidyl Peptidase-4 Inhibitors and the Risk of Heart Failure: a Systematic Review and Meta-Analysis
2011/064352 Al
Stembook 2018.Pdf
A Abacavir Abacavirum Abakaviiri Abagovomab Abagovomabum
Current Progress in Pharmacogenetics of Second-Line Antidiabetic Medications: Towards Precision Medicine for Type 2 Diabetes
Extended Commentary from the American Diabetes Association
Towards Precision Medicine for Type 2 Diabetes
Product List
Supplementary Information Drug Repurposing: Dipeptidyl Peptidase IV
VA/Dod CLINICAL PRACTICE GUIDELINE for the MANAGEMENT of CHRONIC KIDNEY DISEASE
Dipeptidyl Peptidase DPP
PIPELINE PREVIEW: 2016-2017 a SUMMARY of the PHARMACEUTICAL PIPELINE Maria M
O-Ribose Methyltransferase Nsp16 of SARS-Cov-2
Appendix: NMA of Comparative Efficacy of Semaglutide to SGLT-2Is in Patients Inadequately Controlled on 1-2 Oads
Dipeptidyl Peptidase (DPP)-IV Inhibitors with Antioxidant Potential Isolated from Natural Sources: a Novel Approach for the Management of Diabetes
Top View
Wo 2013/054345 A2 ©
(12) Patent Application Publication (10) Pub. No.: US 2016/0082123 A1 RAU Et Al
In Silico Evaluation of the Effectivity of Approved Protease Inhibitors
Rethinking Innovation: the Case of Diabetes Drug Discovery
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Pharmacology 3 3 2017.Pdf
Download the ACPE Poster Abstracts
Combination of Sodium-Glucose Cotransporter 2 Inhibitor And
A Comprehensive Review and Perspective on Natural Sources As Dipeptidyl Peptidase-4 Inhibitors for Management of Diabetes
2015 ADA Posters 929-1473.Indd
WO 2016/192680 Al 8 December 2016 (08.12.2016) P O P C T
Design and Synthesis of Novel Drug Candidates for The
Biocatalyzed Synthesis of Antidiabetic Drugs: a Review
In Silico Discovery of Potential Inhibitors Against Dipeptidyl Peptidase-4: a Major Biological Target of Type-2 Diabetes Mellitus
WO 2017/095725 Al 8 June 2017 (08.06.2017) W P O P C T
Lowering Drugs on Body Weight in People with Type 1 Diabetes: a Systematic Review and Network Meta-Analysis Protocol
BMJ Open Is Committed to Open Peer Review. As Part of This Commitment We Make the Peer Review History of Every Article We Publish Publicly Available
Dipeptidyl Peptidase DPP
Identification and Characterization of Antidiabetic And
An Integrated in Silico and in Vitro Assays of Dipeptidyl Peptidase-4 and Α-Glucosidase Inhibition by Stellasterol from Ganoderma Australe
Drug Repurposing: Dipeptidyl Peptidase IV (DPP4) Inhibitors As Potential Agents to Treat SARS-Cov-2 (2019-Ncov) Infection
INN-Nimet 1 20.8.2019 a Abacavir Abacavirum Abakaviiri